Budget carrier Cebu Pacific on Monday announced promotional one-way base fares as low as P388 for flights to Singapore. In an advisory, the airline said the promo fares—P388 from Manila, P488 from ...
Copyright 2020 FactSet Research Systems Inc. All rights reserved. Source: FactSet Fundamentals Stocks: Real-time U.S. stock quotes reflect trades reported through ...
When AMD revealed the Ryzen AI Max 300 series, also known by its codename "Strix Halo", there were only three models: the eight-core 385, the twelve-core 390, and the 16-core "Max+ 395". That plus ...
AMD is no stranger to making CPUs with powerful integrated GPUs. However, a leaked new chip, called the AMD Ryzen AI Max+ 388, could be one of its most exciting yet. It appears to be based on the ...
TL;DR: AMD's upcoming Ryzen AI Max+ 388 "Strix Halo" APU features an 8-core, 16-thread Zen 5 CPU paired with the powerful 40-core Radeon 8060S GPU, delivering high-performance gaming and efficient ...
A new AMD processor might be on the way, and it’s shaping up to be a smart midrange option for gamers and compact PC fans. The rumored chip, called the Ryzen AI Max+ 388, has been spotted in the ...
AMD’s secret weapon against Nvidia’s gaming products isn’t another graphics card but a “Max” chip that has the capability to do everything, everywhere, all at once. The company’s Strix Halo lineup, ...
TL;DR: Intel's upcoming Panther Lake laptop processors will launch as the Core Ultra 300 series, featuring a new Core Ultra X tier with enhanced Xe3 GPU cores for superior graphics performance. The ...
Japanese drugmaker Chugai Pharmaceutical (TYO: 4519) has concluded a license agreement with Roche (ROG: SIX) for CT-388, a long-acting GLP-1/GIP receptor agonist, currently in development for obesity ...
Chugai Pharmaceutical Co., Ltd. announced that it has concluded a license agreement with F. Hoffmann-La Roche Ltd (Roche) for CT-388, a long-acting GLP-1/GIP receptor agonist, currently in development ...
Rumor mill: Intel's upcoming Panther Lake CPU lineup has been making headlines as of late, particularly after the company shared an architectural overview with journalists during last month's Tech ...
Swiss pharma major Roche (ROG: SIX) has unveiled its long-awaited plan to crack the booming obesity market, targeting a top-three position before 2030. At its Pharma Day presentation in London, pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback